Mingan Chen

Mingan Chen

Auto-generated profile, based on publicly available information

Mingan Chen

Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2024 in Nature Methods
Verified
Journal Article
Closed access
PDF file
DCDuanhua Cao
Duanhua Cao
MCMingan Chen
Mingan Chen
RZRunze Zhang
Runze Zhang
ZWZhaokun Wang
Zhaokun Wang
MHManlin Huang
Manlin Huang
MZMingyue Zheng
Mingyue Zheng

3 January 2024 in Medicinal Research Reviews
Verified
Journal Article
Closed access
MCMingan Chen
Mingan Chen
XJXinyu Jiang
Xinyu Jiang
LZLehan Zhang
Lehan Zhang
XCXiaoxu Chen
Xiaoxu Chen
YWYiming Wen
Yiming Wen
MZMingyue Zheng
Mingyue Zheng

28 June 2022 in Chemical Communications
Verified
Journal Article
Open access
PDF file
MCMingan Chen
Mingan Chen
HYHUI YANG
HUI YANG
Ming Wah WongMing Wah Wong
Ming Wah Wong
A computational DFT-D3 study revealed a new polymerization-like mechanism comprising alternate epoxide and CO2 activation steps and a nested CO2 activation pathway for CO2 fixation of epoxides catalyzed by multifunctional non-halide organocatalysts.

30 June 2026 in Nature Communications
Verified
Journal Article
Open access
XJXinyu Jiang
Xinyu Jiang
MCMingan Chen
Mingan Chen
CZChuanlong Zeng
Chuanlong Zeng
DCDuanhua Cao
Duanhua Cao
JYJie Yu
Jie Yu
MZMingyue Zheng
Mingyue Zheng
Accurate descriptions of interactions between atoms are essential for molecular simulations used to study biology and support drug discovery. Existing force fields often face a trade-off between physical reliability, computational efficiency, and accuracy across unfamiliar molecules. Here we show that Residual Learning Force Field, a hybrid machine learning force field, can reduce this trade-off by combining simple physics-based descriptions of bonded interactions with learned corrections for remaining energetic effects. The two components are trained together through a three-step strategy so that each contributes complementary information. In tests covering drug-like molecules, molecular dimers, torsional energy profiles, energy-minimum structures, and biomolecular simulations, Residual Learning Force Field gives accurate and stable predictions across diverse systems. These results suggest that combining physical constraints with data-driven corrections can provide a practical route toward more reliable and efficient molecular simulation for biological research and drug discovery.

1 October 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
DCDuanhua Cao
Duanhua Cao
ZFZhehuan Fan
Zhehuan Fan
JYJie Yu
Jie Yu
MCMingan Chen
Mingan Chen
XJXinyu Jiang
Xinyu Jiang
MZMingyue Zheng
Mingyue Zheng
Advances in protein structure prediction have created opportunities for structure-based drug design, yet translating structural knowledge into actionable small-molecule ligands remains difficult. Existing benchmarks often use simplified datasets and computational surrogates that poorly capture the heterogeneity and constraints of real-world drug discovery. We introduce MolGenBench, a comprehensive benchmark for de novo molecular generation and hit-to-lead optimization built on a large, structurally diverse dataset. Evaluation of 17 leading methods reveals persistent limitations, including weak virtual-screening performance, limited coverage of target-specific bioactive space, frequent high-risk structural motifs, poor target awareness, and reduced generalization to unseen proteins. Although some models improve three-dimensional conformation generation, they still struggle to produce active molecules reliably. MolGenBench provides standardized data, metrics, and analyses that connect structural prediction with practical molecular design and guide the development of more effective structure-based generative models.